FDA tells Purell to stop claiming it can prevent flu

February 10, 2020

The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.

See the latest posts on our homepage


Share

Topic Area: Infection Control


Recent Posts
Recent Posts

Regulations, Codes & Standards Q&A: Stairwell re-entry signs


Brad Keyes discusses regulations for stairwell re-entry signs

2/26/2020

Blog / Focus: Facility Design

It’s time to update your collaboration spaces


Companies that offer flexible geographic, collaborative and high-tech work environments have reported their workers are happier and more likely to stay with that place of employment

2/26/2020

Case study / Lighting

Improving patient outcomes through daylight


Sprawling Parkland Memorial Hospital site adapts for future, automates for performance

2/26/2020

City of St. Louis Renews Corizon Health Partnership


2/26/2020

Robotics company brings fresh healthy food to hospitals 24/7


2/26/2020





Post Comment




FREE
NEWSLETTER

News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.